Why is Venus Remedies falling/rising?

Short-Term Price Movement and Market Context

Venus Remedies’ share price dropped by ₹28.15 on 17-Dec, marking a 3.53% decrease from the previous close. Intraday, the stock touched a low of ₹758.40, representing a 4.86% fall from its prior levels. This decline is significant given the stock’s recent outperformance relative to the broader market and its sector peers. Over the past week, the stock has declined by 2.23%, while the Sensex benchmark index gained 0.20%, indicating that Venus Remedies underperformed the market in the short term.

Despite this recent dip, the stock’s longer-term returns remain robust. Over the past month, Venus Remedies surged by 38.36%, substantially outperforming the Sensex, which declined by 0.46% during the same period. Year-to-date, the stock has delivered an impressive 144.01% gain, dwarfing the Sensex’s 8.22% rise. Even over one, three, and five-year horizons, Venus Remedies has consistently outpaced the benchmark, with returns exceeding 130%, 300%, and 450% respectively, compared to the Sensex’s more modest gains.

Technical Indicators and Trading Activity

From a technical standpoint, Venus Remedies’ current price remains above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling a generally positive medium- to long-term trend. However, the stock is trading below its 5-day moving average, suggesting some short-term weakness or profit-taking by traders. This divergence between short- and long-term moving averages often reflects a temporary correction within an overall upward trajectory.

Trading volumes also provide insight into the stock’s recent price action. On 16-Dec, the delivery volume was recorded at 1.92 lakh shares, which represents a sharp decline of 44.86% compared to the five-day average delivery volume. This drop in investor participation indicates reduced conviction among buyers, potentially contributing to the downward pressure on the stock price. Additionally, the weighted average price for the day showed that more volume was traded near the day’s low, reinforcing the notion of selling pressure dominating the session.

Liquidity and Market Impact

Liquidity remains adequate for Venus Remedies, with the stock’s traded value supporting transactions of up to ₹0.1 crore based on 2% of the five-day average traded value. This level of liquidity ensures that the stock can absorb moderate trade sizes without excessive price disruption, although the recent decline suggests that sellers have had the upper hand in the short term.

Balancing Strong Fundamentals with Short-Term Volatility

While Venus Remedies has demonstrated exceptional returns over multiple time frames, the recent price decline on 17-Dec highlights the volatility that can occur even in fundamentally strong stocks. The underperformance relative to the sector and benchmark indices on this day, combined with falling delivery volumes and trading concentrated near the intraday lows, suggests that some investors may be booking profits or exercising caution amid broader market uncertainties.

Without specific positive or negative news releases available for the day, the price movement appears to be driven primarily by technical factors and shifts in investor sentiment. The stock’s ability to maintain levels above key moving averages indicates that the underlying trend remains intact, but the short-term correction serves as a reminder of the importance of monitoring volume and price action closely.

Investors considering Venus Remedies should weigh its impressive historical performance against the current signs of reduced participation and short-term pressure. Such fluctuations are common in high-growth stocks and may present opportunities for disciplined investors to enter or add to positions at more favourable prices.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →